Dr. Poll is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
New Albany, OH
New Albany, OH 43054Phone+1 614-580-2022
Summary
- I practiced for 22 years, the last 9 restricting the practice to Lap Nephrectomy and then robotic Prostates. In 2009 I left practice to become CEO of a VC-backed device company, and created an endoscopic vision products called: FloShield.
Next, I was CEO of a robotic HIFU company.
Now, I consult for development stage companies, combining my clinical experience and knowledge of engineering and commercialization
Education & Training
- Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 1986 - 1986
- Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 1984 - 1984
- University of ConnecticutResidency, Surgery, 1981 - 1983
- Vanderbilt University School of MedicineClass of 1981
- Duke UniversityA.B., Chemistry, Summa Cum Laude, 1977
Certifications & Licensure
- OH State Medical License 1987 - 2026
Awards, Honors, & Recognition
- Robotic FloShieldTM 1st Place Excellence in Surgical Products Award 2014
- Recipient of R&D Healthcare Award Columbus CEO Magazine, 2013
- First Place, Start-Up of the Year, TechColumbus Innovation Awards Minimally Invasive Devices, Inc., 2011
- Join now to see all
Publications & Presentations
PubMed
- 103 citationsRandomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate CancerTomasz M. Beer, Guy T. Bernstein, John M. Corman, L. Michael Glode, Simon J. Hall
Clinical Cancer Research. 2011-07-01 - 4 citationsRobotic Radical Prostatectomy at a Teaching Community Hospital: Outcomes and SafetyJulianna Padavano, Lynn E.T. Shaffer, Elizabeth A. Fannin, John Burgers, Wayne Poll
JSLS. 2011-04-01 - 1 citationsDerision is the sweet spot of adoption: unleashing disruptive growth.Wayne Poll
Hospital Topics. 2011-02-24
Press Mentions
- Personal View: How Suspending the Device Tax Is Driving InnovationJune 5th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: